E. S. Akyol Et Al. , "Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker," ACTA NEUROPSYCHIATRICA , vol.29, no.2, pp.80-86, 2017
Akyol, E. S. Et Al. 2017. Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker. ACTA NEUROPSYCHIATRICA , vol.29, no.2 , 80-86.
Akyol, E. S., ALBAYRAK, Y., Aksoy, N., Sahin, B., BEYAZYÜZ, M., Kuloglu, M., ... Hashimoto, K.(2017). Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker. ACTA NEUROPSYCHIATRICA , vol.29, no.2, 80-86.
Akyol, Esra Et Al. "Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker," ACTA NEUROPSYCHIATRICA , vol.29, no.2, 80-86, 2017
Akyol, Esra S. Et Al. "Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker." ACTA NEUROPSYCHIATRICA , vol.29, no.2, pp.80-86, 2017
Akyol, E. S. Et Al. (2017) . "Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker." ACTA NEUROPSYCHIATRICA , vol.29, no.2, pp.80-86.
@article{article, author={Esra Soydas Akyol Et Al. }, title={Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarker}, journal={ACTA NEUROPSYCHIATRICA}, year=2017, pages={80-86} }